Articles Tagged With: labeling
-
Report Details Effect of Mifepristone Labeling Change
New research indicates that for Texas providers and patients, the 2016 Food and Drug Administration’s (FDA) new labeling for the abortion drug mifepristone increased access options and brought the proportion of medication abortions in the state into alignment with national data.
-
Report: Abortion Safe, but Access to the Procedure May Be Limited
A new report has determined that while abortion in the United States is safe, the quality of abortion care depends on where a woman lives.
-
New Prescription Drug Labeling for Pregnant and Nursing Women
The FDA has updated the requirements for the pregnancy and lactation sections of drug labeling to allow pregnant women and their healthcare providers to be better informed about the risks and benefits of medications while pregnant or nursing. This article discusses the new Pregnancy and Lactation Labeling Rule that went into effect in June 2015 and is being phased in over the next three to five years.